cal-101
Showing 1 - 3 of 3
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)
Active, not recruiting
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
Apr 29, 2022
Allergic Rhinitis Trial in Vienna (CAL-101, Placebo)
Completed
- Allergic Rhinitis
- CAL-101
- Placebo
-
Vienna, AustriaVienna Challenge Chamber
Oct 19, 2018
Chronic Lymphocytic Leukemia (CLL), Lymphoma, Non-Hodgkin (NHL), Acute Myeloid Leukemia (AML) Trial in United States (CAL-101)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- +3 more
- CAL-101
-
Palo Alto, California
- +8 more
Aug 29, 2012